COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 512: Articles 5111-5120  | Next

A Transformer-Based Model Trained on Large Scale Claims Data for Prediction of Severe COVID-19 Disease Progression
Lentzen, M., Linden, T., Veeranki, S., Madan, S., Kramer, D., Leodolter, W., Froehlich, H., COPERIMOplus
10.1101/2022.11.29.22282632 — Posted: 2022-11-30
Continuous Positive Airway Pressure (CPAP) in Covid 19 Acute Respiratory Distress Syndrome (ARDS): A Systematic Review
Hoole, A.
10.1101/2022.11.29.22282819 — Posted: 2022-11-30
Mental Health, Substance Use, and the Importance of Religion during the COVID-19 Pandemic
Park, J.-Y., Galbadage, T., Lee, H., Wang, D. C., Peterson, B. M.
10.1101/2022.11.29.22282907 — Posted: 2022-11-30
Targeted photodynamic neutralization of SARS-CoV-2 mediated by singlet oxygen
Yao, R., Hou, J., Zhang, X., Li, Y., Lai, J., Wu, Q., Liu, Q., Zhou, L.
10.1101/2022.11.29.518438 — Posted: 2022-11-30
Effect of COVID-19 during pregnancy: Studying the maternal and neonatal outcomes and assessing the placental changes related to SARS-CoV-2
Madan, S., Ramar, D., Patel, D., Shah, N., Shah, B., Thakkar, V., Shah, H., Chovatia, R., Dabhi, P., Patel, M., Patel, A., Bapat, N., Bhatt, P., Naik, A., Rana, M., Nayak, H., Sharma, K. D., Parikh, P., Mehta, B.
10.1101/2022.11.29.22282903 — Posted: 2022-11-30
Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population
Wei, J., Matthews, P. C., Stoesser, N., Newton, J., Diamond, I., Studley, R., Taylor, N., Bell, J., Farrar, J., Marsden, B., Kolenchery, J., Hoosdally, S., Jones, Y., Stuart, D., Crook, D., Peto, T. E., Walker, A. S., Pouwels, K., Eyre, D. W.
10.1101/2022.11.29.22282916 — Posted: 2022-11-30
SARS-CoV-2 Envelope-mediated Golgi pH dysregulation interferes with ERAAP retention in cells
Vargas-Zapata, V., Geiger, K. M., Tran, D., Ma, J., Mao, X., Puschnik, A. S., Coscoy, L.
10.1101/2022.11.29.518257 — Posted: 2022-11-30
An Optimized Circular Polymerase Extension Reaction-based Method for Functional Analysis of SARS-CoV-2
Liu, G., Gack, M.
10.1101/2022.11.26.518005 — Posted: 2022-11-30
Epidemiological impact of a large number of incorrect negative SARS-CoV-2 test results in South West England during September and October 2021
Hounsome, L., Herr, D., Bryant, R., Smith, R., Loman, L., Harris, J., Youhan, U., Dzene, E., Hadjipantelis, P., Long, H., Laurence, T., Riley, S., Cumming, F.
10.1101/2022.11.30.22282922 — Posted: 2022-11-30
Vaccine hesitancy, reactogenicity and immunogenicity of BNT162b2 and CoronaVac in pediatric patients with neuromuscular diseases
Yu, M. K. L., Chan, H. S. S., Cheng, S., Leung, D., Chan, S. M., Suen, A. K. Y., Wong, W. H. S., Peiris, M., Lau, Y. L., Rosa Duque, J. S.
10.1101/2022.11.29.22282857 — Posted: 2022-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).